TVRD

Tvardi Therapeutics, Inc. Common Stock

101 hedge funds and large institutions have $129M invested in Tvardi Therapeutics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 31 increasing their positions, 23 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
101
Holders Change
+20
Holders Change %
+24.69%
% of All Funds
2.53%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
32
Increased
31
Reduced
23
Closed
12
Calls
$1.78M
Puts
$583K
Net Calls
+$1.19M
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Renaissance Technologies
101
Renaissance Technologies
New York
-$2.07M -6,886 Closed
EMG
102
Ellington Management Group
Connecticut
-$780K -2,594 Closed
PAM
103
Princeton Alpha Management
New Jersey
-$369K -1,229 Closed
AQR Capital Management
104
AQR Capital Management
Connecticut
-$349K -1,163 Closed
GCP
105
GSA Capital Partners
United Kingdom
-$327K -1,089 Closed
VKH
106
Virtu KCG Holdings
New York
-$248K -824 Closed
Jane Street
107
Jane Street
New York
-$220K -732 Closed
ProShare Advisors
108
ProShare Advisors
Maryland
-$161K -536 Closed
HCM
109
Highbridge Capital Management
New York
-$105K -348 Closed
Tudor Investment Corp
110
Tudor Investment Corp
Connecticut
-$104K -346 Closed
PHK
111
Point72 Hong Kong
Hong Kong
-$31K -103 Closed
NFG
112
Next Financial Group
Texas
-$2K -7 Closed